| Literature DB >> 22182958 |
Abstract
In 2011, both the PARTNER-A trial, in high-risk patients with severe aortic stenosis, and EVEREST II, in patients with mitral insufficiency, showed noninferiority of transcatheter interventions compared with surgery for the chosen primary end points. However, both of the trials, and important registry data, identified limitations of transcatheter valve interventions.Entities:
Mesh:
Year: 2011 PMID: 22182958 DOI: 10.1038/nrcardio.2011.204
Source DB: PubMed Journal: Nat Rev Cardiol ISSN: 1759-5002 Impact factor: 32.419